Table 2.

Responses to ASC Questionnaire

Specific Type of Cancer-Related Worry	Thyroid Cancer Canada Participants	Published Mixed Cancer Survivorsa
Entire study population	n = 940	n = 753 for study
Cancer worry questionsb,c
Future tests	2.46 (0.97)	2.56 (1.18)
New cancer	2.65 (0.95)	2.67 (1.17)
Recurrence	2.60 (0.98)	2.60 (1.19)
Health worry questionsb,c
Death	2.12 (0.99)	1.37 (0.69)
Health	2.77 (0.92)	1.73 (0.85)
Children's healthd	2.74 (0.97)	1.57 (0.86)
Long-term cancer survivorse	n = 318	n = 161 for study
Cancer worry questionsf,g
Future tests	2.33 (0.90)	2.61 (1.11)
New cancer	2.58 (0.89)	2.75 (1.12)
Recurrence	2.47 (0.90)	2.69 (1.16)
Health worry questionsf,g
Death	2.07 (0.94)	1.37 (0.72)
Health	2.66 (0.92)	1.86 (0.93)
Children's healthh	2.72 (0.94)	1.72 (0.90)

Data are expressed as mean score (SD). Possible range is 1 to 4, with greatest worry 4.

^aRef. 12.

^bPercentage of missing responses to respective questions in the entire thyroid cancer population: tests, 0.3% (3 of 941); another cancer, 0.2% (2 of 941); recurrence, 0.6% (6 of 941); dying, 0.5% (5 of 941); health, 0.3% (3 of 941); children's health, 0.2% (2 of 941), including one individual who did not respond to any ASC questions.

^cPercentage of missing responses to respective questions in the entire mixed oncology population as previously reported by Gotay et al (12): tests, 4.0% (30 of 753); another cancer, 4.4% (33 of 753); recurrence, 2.9% (22 of 753); dying, 2.7% (20 of 753); health, 2.0% (15 of 753); children's health, 18.6% (140 of 753).

^dFor the question on children's health (in the entire thyroid cancer study population), the percentage of responses indicating “not applicable” was 26.5% (249 of 941), of which 95.6% (239 of 249) were in individuals without children.

^eLong-term cancer survivors are defined as >5 years since initial diagnosis in the thyroid cancer population, or 5–6 years after diagnosis in the mixed oncology population, respectively.

^fPercentage of missing responses to respective questions in the long-term thyroid cancer subgroup population: tests, 0.6% (2 of 319); another cancer, 0.6% (2 of 319); recurrence, 1.9% (6 of 319); dying, 1.3% (4 of 319); health, 0.9% (3 of 319); children's health, 0.6% (2 of 319), including one individual who did not respond to any ASC questions.

^gPercentage of missing responses to respective questions in the long-term survivor subgroup of the mixed oncology population, as previously reported by Gotay et al. (12): tests, 2.5% (4 of 161); another cancer, 2.5% (4 of 161); recurrence, 0.6% (1 of 161); dying, 1.9% (3 of 161); health, 0.6% (1 of 161); children's health, 16.8% (27 of 161).

^hFor the question on children's health (in the long-term thyroid cancer subgroup population), the percentage of responses indicating “not applicable” was 26.3% (84 of 319).